Alemtuzumab and neutropenia 
Alemtuzumab and neutropenia Patient Reports February 13, 2012
Alemtuzumab Side Effects Report #5782664-3
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, urinary tract infection
, zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.Alemtuzumab Side Effects Report #5787439-7
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, urinary tract infection
, zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.Alemtuzumab Side Effects Report #5795840-0
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, surgical procedure repeated, transplant, transplant rejection, urinary tract infection
, zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.Alemtuzumab Side Effects Report #5597999-7
Alemtuzumab side effect was reported by a Physician from GERMANY on Jan 15, 2008. Male patient, 63 years of age, weighting 149.9 lb, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, leukopenia, neutropenia, pain
, proteinuria. Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, TAMSULOSIN, TRIMIPRAMINMALEAT, TIOTROPIUMBROMID, FORMOTEROLHEMIFUMARAT, CIPROFLOXACIN, PREDNISOLONE. Patient was hospitalized. Patient died on 12/24/2007.Alemtuzumab Side Effects Report #6114788-5
Alemtuzumab side effect was reported by a Physician from GERMANY on Mar 06, 2009. Male patient, 63 years of age, weighting 149.9 lb, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chronic lymphocytic leukaemia, chronic obstructive pulmonary disease, dyspnoea, leukopenia, neutropenia, pain
, pneumonia . Alemtuzumab dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, TAMSULOSIN, TRIMIPRAMINMALEAT, TIOTROPIUMBROMID, FORMOTEROLHEMIFUMARAT, CIPROFLOXACIN, PREDNISOLONE. Patient was hospitalized. Patient died on 12/24/2007.Alemtuzumab Side Effects Report #5645801-7
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2008. Male patient, 46 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent, antiviral prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: local swelling, lymphadenopathy, mycobacterium avium complex infection, neutropenia. Alemtuzumab dosage: unknown. During the same period patient was treated with FAMCICLOVIR, SULFAMETHOXAZOLEF. Patient recovered.
Alemtuzumab Side Effects Report #5694796-9
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2008. Male patient, 55 years of age, was diagnosed with chronic lymphocytic leukaemia, enterococcal infection, klebsiella infection and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: bacterial infection
, bronchopulmonary aspergillosis, febrile neutropenia, pancytopenia. Alemtuzumab dosage: unknown. During the same period patient was treated with QUINUPRISTIN, MEROPENEM. Patient was hospitalized. Patient died.Alemtuzumab Side Effects Report #5695685-6
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2008. Male patient, 55 years of age, was diagnosed with chronic lymphocytic leukaemia, enterococcal infection, klebsiella infection and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: bacterial infection
, bronchopulmonary aspergillosis, febrile neutropenia, pancytopenia. Alemtuzumab dosage: unknown. During the same period patient was treated with QUINUPRISTIN, MEROPENEM. Patient was hospitalized. Patient died.